BioSpace News Archive

Business

Seagen Reports Third Quarter 2022 Financial Results

Seagen Inc. (Nasdaq:SGEN) reported financial results today for the third quarter ended September 30, 2022.

October 27, 2022
·
16 min read
BioMidwest

Sonoma Pharmaceuticals Launches Two New Dermatological Products for Over-The-Counter Use in the United States

Sonoma Pharmaceuticals, Inc. announced that it has launched Reliefacyn® Advanced Itch-Burn-Rash-Pain Relief Hydrogel and Rejuvacyn® Advanced Skin Repair Cooling Mist direct to consumers for over-the-counter use in the United States.

October 27, 2022
·
5 min read
Business

enVVeno Medical Reports Third Quarter 2022 Financial Results and Provides Corporate Update

enVVeno Medical Corporation, a company setting new standards of care for the treatment of venous disease, provided a corporate update and reported financial results for the third quarter ended September 30, 2022.

October 27, 2022
·
6 min read
Genetown

Moderna to Host First Environmental, Social and Governance (ESG) Day on November 10, 2022

Moderna, Inc., a biotechnology company pioneering messenger RNA therapeutics and vaccines, announced that it will host its first virtual ESG Day for analysts and investors at 9:00 a.m. ET on Thursday, November 10.

October 27, 2022
·
1 min read
Autologous Cell Therapy Market Size to Surpass USD 34.94 BN by 2030

According to Latest Report Study, the global autologous cell therapy market is predicted to surpass around USD 34.94 billion by 2030 with a CAGR of 18.13% from 2022 to 2030.

October 27, 2022
·
6 min read
Proteinase K Market Size to Hit Around USD 7.98 Billion by 2030

According to Vision Research Reports, the global proteinase K market size was garnered at USD 3.7 billion in 2021 and is expected to hit around USD 7.98 billion by 2030, growing at a CAGR of 8.92% from 2022 to 2030.

October 27, 2022
·
10 min read
Retinal Vein Occlusion Treatment Market Size to Garner USD 34.88 BN by 2030

According to Vision Research Reports, the global retinal vein occlusion treatment market size is expected to surpass around USD 34.88 billion by 2030 and poised to grow at a CAGR of 7.42% from 2022 to 2030.

October 27, 2022
·
3 min read
Carbapenem Market Size, Growth, Trends | Report 2022-2030

Carbapenem market is majorly driven by the rising prevalence of infectious diseases such as urinary tract infections (UTIs), intra-abdominal infections, & bacterial meningitis and the increasing movement of generic product companies.

October 27, 2022
·
3 min read
AI In Cancer Diagnostics Market Size USD 1.2 BN by 2030 With a CAGR of 28.9%

Latest Study on “AI In Cancer Diagnostics Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2022-2030”.

October 27, 2022
·
5 min read
Cancer Diagnostics Market Size to Hit Around USD 293.8 BN by 2030

According to Nova one advisor, the global Cancer Diagnostics market size was valued at USD 160.9 billion in 2021 and is predicted to hit USD 293.8 billion by 2030 with a registered CAGR of 6.90% during the forecast period 2022 to 2030.

October 27, 2022
·
7 min read